ArticleThe Journal of clinical investigation2021

Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis.

Christian F Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.